Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
PagerDuty
PD
$871M
| $2.41M | ﹤0.01% |
104,418
+36,250
| +53% | +$936K |
|
1577
Qualys
QLYS
$5.67B
| $2.41M | ﹤0.01% |
17,277
+6,598
| +62% | +$930K |
|
1578
Altimmune
ALT
$597M
| $2.4M | ﹤0.01% |
187,964
-877,583
| -82% | -$13M |
|
|
JJN
1579
DELISTED
iPath Series B Bloomberg Nickel Subindex Total ReturnSM ETN
JJN
| $2.4M | ﹤0.01% |
85,000
| – | – |
|
|
CHS
1580
DELISTED
Chicos FAS, Inc.
CHS
| $2.4M | ﹤0.01% |
495,752
-121,633
| -20% | -$676K |
|
1581
Applied Industrial Technologies
AIT
$13.2B
| $2.39M | ﹤0.01% |
23,300
-1,034
| -4% | -$106K |
|
1582
Ligand Pharmaceuticals
LGND
$6.03B
| $2.39M | ﹤0.01% |
44,520
+35,502
| +394% | +$2.09M |
|
1583
Rocket Pharmaceuticals
RCKT
$376M
| $2.39M | ﹤0.01% |
149,833
+32,480
| +28% | +$507K |
|
|
GMFI
1584
DELISTED
Aetherium Acquisition Corp
GMFI
| $2.39M | ﹤0.01% |
240,015
+15
| +0% | +$149 |
|
|
ENPC
1585
DELISTED
Executive Network Partnering Corporation
ENPC
| $2.39M | ﹤0.01% |
239,205
| – | – |
|
1586
Ginkgo Bioworks
DNA
$612M
| $2.38M | ﹤0.01% |
19,079
+11,400
| +148% | +$1.36M |
|
1587
Selective Insurance
SIGI
$5.76B
| $2.38M | ﹤0.01% |
29,207
+1,614
| +6% | +$132K |
|
1588
Sonoco
SON
$5.8B
| $2.37M | ﹤0.01% |
41,786
+18,208
| +77% | +$1.12M |
|
|
SMAR
1589
DELISTED
Smartsheet Inc.
SMAR
| $2.37M | ﹤0.01% |
68,997
+48,822
| +242% | +$1.65M |
|
1590
Valmont Industries
VMI
$9.72B
| $2.37M | ﹤0.01% |
8,819
+1,619
| +22% | +$428K |
|
|
CDMO
1591
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.36M | ﹤0.01% |
123,510
+104,317
| +544% | +$1.9M |
|
|
PACX
1592
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $2.36M | ﹤0.01% |
236,968
| – | – |
|
1593
Enanta Pharmaceuticals
ENTA
$387M
| $2.35M | ﹤0.01% |
45,368
+39,571
| +683% | +$2.31M |
|
1594
Perrigo
PRGO
$1.49B
| $2.34M | ﹤0.01% |
65,691
-74,691
| -53% | -$3M |
|
1595
Urban One Class D
UONEK
$26.1M
| $2.34M | ﹤0.01% |
55,085
+23,525
| +75% | +$993K |
|
1596
AbCellera Biologics
ABCL
$1.86B
| $2.34M | ﹤0.01% |
236,398
-4,830
| -2% | -$53K |
|
1597
Varex Imaging
VREX
$521M
| $2.33M | ﹤0.01% |
110,424
-3,897
| -3% | -$85.2K |
|
1598
PUT
Alcon
ALC
$34.6B
| $2.33M | ﹤0.01% |
+40,000
| New | +$2.77M |
|
1599
Exponent
EXPO
$3.29B
| $2.32M | ﹤0.01% |
26,510
+9,680
| +58% | +$918K |
|
1600
Genpact
G
$6.07B
| $2.32M | ﹤0.01% |
52,980
-21,451
| -29% | -$986K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.